Past Meetings
749 meetings available
Antalya, Türkiye
12th Turkish Medical Oncology Congress
Joint session with ESMO
Chongqing and online, China
Best of ESMO Breast Cancer - China Forum
- Languages:
- English
- Chinese
Lima, Peru
ESMO Summit Latin America 2025
Lima, Peru
ESMO Preceptorship on Breast Cancer 2025: Lima
Lima, Peru
ESMO Preceptorship on Gastroesophageal Cancer 2025: Lima
Athens, Greece
31st Hellenic Conference of Clinical Oncology
Joint session with ESMO
- CME:
- 25 cat.1 ESMO-MORA points
- Organiser:
- HeSMO - Hellenic Society of Medical Oncology
- Languages:
- English
- Greek
Zurich, Switzerland
ESMO Preceptorship on Metastatic Bladder and Kidney Cancer 2025: Zurich
- CME:
- 9 ESMO-MORA category 1 points
ESMO Deep Dive: Lung Cancer - Advanced NSCLC - Non-oncogene Addicted 2025
ESMO Guidelines: Real World Cases - Webinar Series: EGFR-mutated Metastatic Non-small Cell Lung Cancer 2025
Room N02
Optimising Diagnosis and Management of Patients with Oncogene-Addicted Localised Non-small Cell Lung Cancer
This educational activity is provided by ESMO and supported by Eli Lilly and Company
Paris, France
European Lung Cancer Congress 2025
ESMO Booth #480, Exhibition Area
Lugano, Switzerland
ESMO Sarcoma and Rare Cancers Congress 2025
ESMO Virtual Journal Club: March 2025
ESMO Webinar: Advanced Gastric Cancer 2025
Manchester, United Kingdom
ESMO - The Christie Preceptorship on Lung Cancer 2025: Manchester
- CME:
- 16 ESMO-MORA category 1 points
Kobe, Japan
2025 the Japanese Society of Medical Oncology Annual Meeting (JSMO2025)
Joint Session with ESMO
ESMO Deep Dive: Lung Cancer - Non-metastatic NSCLC - Multidisciplinary State of the Art 2025
Paris, France
ESMO Targeted Anticancer Therapies Congress 2025
ESMO Guidelines: Real World Cases - Webinar Series: Bladder Cancer 2025
ESMO Webinar: Advanced Urothelial Cancer 2025
Istanbul, Türkiye
Women’s Oncology Summit: Updates from ESMO
- Languages:
- English
Lugano, Switzerland
ESMO Preceptorship on Lung and Digestive Neuroendocrine Neoplasms 2025: Lugano
- CME:
- 9 ESMO-MORA category 1 points
ESMO Virtual Plenary: Datopotamab deruxtecan (Dato-DXd) vs chemotherapy (CT) in previously-treated inoperable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2–) breast cancer (BC): Final overall survival (OS) from the phase III TROPION-Breast01 trial
Cape Town, South Africa
ESMO Summit Africa 2025
Cape Town, South Africa
ESMO Preceptorship on Cervical Cancer 2025: Cape Town
- CME:
- 9 ESMO-MORA category 1 points
Cairo and online, Egypt
Best of ESMO Egypt
- Languages:
- English
ESMO Deep Dive: Lung Cancer - Precision Oncology in Lung Cancer - Diagnostics 2025
Barcelona, Spain
ESMO Resilience Task Force Workshop: Leading For Better Mental Health, Well-being And Resilience Of The Oncology Workforce